POU4F1 confers trastuzumab resistance in HER2-positive breast cancer through regulating ERK1/2 signaling pathway
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference23 articles.
1. Biomarkers for HER2-positive metastatic breast cancer: beyond hormone receptors;Dieci;Canc. Treat Rev.,2020
2. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine;Ross;Oncol.,2009
3. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer;Valabrega;Ann. Oncol.,2007
4. Neratinib in combination with trastuzumab for the treatment of patients with advanced HER2-positive breast cancer: a phase I/II study;Blackwell;Clin. Breast Canc.,2019
5. Establishment of resveratrol and its derivatives as neuroprotectant against monocrotophos-induced alteration in NIPBL and POU4F1 protein through molecular docking studies;Yadav;Environ. Sci. Pollut. Res. Int.,2020
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of POU4F1 as a novel prognostic biomarker and therapeutic target in esophageal squamous cell carcinoma;Cancer Cell International;2024-08-09
2. Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients;Frontiers in Immunology;2024-06-19
3. The utility of a deep learning-based approach in Her-2/neu assessment in breast cancer;Expert Systems with Applications;2024-03
4. FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma;Journal of Ethnopharmacology;2024-01
5. Xihuang pill facilitates glioma cell pyroptosis via the POU4F1/STAT3 axis;Functional & Integrative Genomics;2023-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3